SILAC-based chemoproteomics reveals a neoligan analogue as an anti-inflammatory agent targeting IRGM to ameliorate cytokine storm
- Resource Type
- Article
- Source
- In
European Journal of Medicinal Chemistry 5 November 2022 241 - Subject
- Language
- ISSN
- 0223-5234